07:50 AM EDT, 05/08/2026 (MT Newswires) -- Novo Nordisk's (NOVO-B.CO) diabetes and weight-loss drug sales in India jumped 40% in April following price cuts, Bloomberg News reported Friday, citing market researcher Pharmarack.

The Danish drugmaker sold 32,000 units of Wegovy, Ozempic, and partner-branded versions during the month.

Novo Nordisk did not immediately respond to a request for comment from MT Newswires.

Novo Nordisk ADR

Senast

45,80

1 dag %

0,00%

1 dag

1 mån

1 år

Novo Nordisk B

Senast

292,50

1 dag %

−1,02%
Marknadsöversikt

1 DAG %

Senast

1 mån